ISRCTN78649100已完成不适用
The effects of sitagliptin (Januvia®) on myocardial performance in patients with coronary artery disease
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Subjects aged 35 - 80 years with coronary disease awaiting revascularisation with normal left ventricular (LV) function with insulin resistance.
排除标准
- •1. Atrial fibrillation
- •2. Pacemakers
- •3. Valvular heart disease
- •4. Renal failure
研究者
相似试验
进行中（未招募）
不适用
The effects of sitagliptin (Januvia) on myocardial performance in patients with coronary artery disease and diabetescoronary artery disease and type 2 diabetes mellitusMedDRA version: 9.1Level: HLTClassification code 10011085Term: Ischaemic coronary artery disordersMedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentEUCTR2008-000300-89-GBCambridge University Hospitals NHS Foundation Trust
进行中（未招募）
不适用
The effect of sitagliptin on myocardial performance in patients with type 2 diabetes and coronary artery disease. - The effect of sitagliptin on LV performance in diabeticsCoronary artery diseaseMedDRA version: 9.1Level: HLTClassification code 10011085Term: Ischaemic coronary artery disordersMedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentEUCTR2009-012776-27-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge20
已完成
不适用
Effect of Sitagliptin on Myocardial function in type-2 diabetic patients complicated by congestive heart failureJPRN-UMIN000012490Department of Cardiology, Osaka Medical College15
招募中
不适用
Effect of Sitagliptin on Plaques and Cardiac Function following ACSAcute Coronary Syndrome end Type 2 Diabetes MellitusJPRN-UMIN000007900ESPECIAL-ACS office46
已完成
不适用
A study investigating the effects of sitagliptin on heart muscle performance in patients with coronary artery disease and diabetesType 2 Diabetes MellitusISRCTN61646154Cambridge University Hospitals NHS Foundation Trust (UK)20